BioVersys
Bioversys AG is a biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Their focus is on creating therapies to combat multidrug-resistant (MDR) bacterial infections, a major global health issue. BioVersys’ proprietary TRIC (Transcriptional Regulator Inhibitory Compounds) technology platform is designed to identify new treatments by inhibiting bacterial resistance mechanisms, thereby making antibiotics more effective.
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does BioVersys use?+
BioVersys uses 19 technologies including Astra, EWWW Image Optimizer, Font Awesome.
What industry is BioVersys in?+
BioVersys operates in the Biopharma industry.
Where is BioVersys based?+
BioVersys is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026